Tirzepatide engages both GLP-1 and GIP receptor pathways simultaneously, offering a novel dual-agonist approach to metabolic health under physician supervision.
Tirzepatide engages both GLP-1 and GIP receptor pathways simultaneously, offering a novel dual-agonist approach to metab…
Physician-SupervisedEvery protocol is physician-designed, pharmacy-compounded, and monitored by your care team from consultation through delivery.
Activates both GLP-1 and GIP receptors — two complementary pathways involved in metabolic regulation.
Your physician titrates your dose based on your response, health history, and goals.
Compounded by a licensed 503A pharmacy to your exact prescription specification.
Consultations, follow-ups, and prescription management handled completely online.
A fully online, physician-supervised process — no office visits required.
Enter your email and confirm your address. Complete your health profile so we're ready when spots open.
Meet virtually with a licensed physician who reviews your goals and health history before writing any prescription.
Your prescription is filled by a licensed 503A compounding pharmacy to pharmaceutical-grade standards.
Temperature-controlled shipping directly to your door with full administration instructions and ongoing support.
Physician-supervised peptide protocols — no commitment, no upfront cost. We'll reach out when your protocol is ready to prescribe.
This website is for informational purposes only and does not constitute medical advice. All protocols require a physician consultation and valid prescription.
*The assessment made available on the Irvine Health website does not create a doctor-patient relationship between the individual completing the assessment and Irvine Health. Irvine Health partners with a network of US-licensed doctors that adhere to rigorous medical protocols designed for patient safety. The answers an individual provides to the Irvine Health assessment consequently determine if the individual is screened out of eligibility for medication, and an Irvine Health clinician will meet with an individual after checkout to determine if they qualify for a prescription. Irvine Health clinicians retain the decision to prescribe compounded medications to patients.
All claims and benefits on this website refer to self-reported data from customers on a treatment plan that includes compounded medications and consultations with medical professionals. Customers reported their weight on their initial medical intake questionnaire every 3–4 weeks thereafter. Results from compounded medications found on the Irvine Health platform may vary and be affected by an individual’s adherence to the program and their clinician’s recommendations. Compounded peptides and GLP-1s are produced in FDA-regulated facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider’s medical judgment, which is informed by a telehealth consultation and medical history.
We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication. Irvine Health does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.
Pharmacy Providers
We are partnered with multiple USA certified pharmacies to bring the best product and overall experience to our membership. Our team meets regularly with pharmacies to discuss any product shortages, shipping delays, and get updated reports on their medication testing.
*Results vary based on starting weight and program adherence. Inches lost from hips, waist, chest, thighs, and arms in the first month. Patients exercised daily and ate a reduced-calorie diet. Their fat loss is not typical. Results may vary. Medication prescriptions are at the discretion of medical providers and may not be suitable for everyone. Consult a healthcare professional before using medication or starting any weight loss program. *Based on the average weight loss as reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity.
Medication is included in the cost of the Irvine Health Program. Wegovy® is FDA-approved for weight loss. Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss. The trademarks, service marks, trade names (Wegovy®, Ozempic®), and products displayed on this Internet site are protected and belong to their respective owners. Medical treatment is provided by Irvine Health affiliated physicians and licensed professional corporations. No data, photos, claims, or any other information is associated with results derived from clinical trials, studies, or public information and is always representative of Irvine Health patient experience.
Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies. No representation or warranty is made regarding the accuracy, completeness, or reliability of such content.
© 2026 Irvine Health LLC. All rights reserved. 19200 Von Karman Avenue, 4th, 5th, and 6th Floors, Irvine, CA 92612.